Literature DB >> 11405072

Anti-oxidative capacity of various artificial tear preparations.

G Rieger1.   

Abstract

BACKGROUND: Increased UV radiation and ozone exposure may cause "dry eyes of environmental origin", if the normal anti-oxidative capacity of the tear film can no longer cope with the oxidative stress. The use of artificial tears with an adequate anti-oxidative effect may be beneficial in the treatment of dry eyes caused by environmental factors.
METHODS: The anti-oxidative capacity of various commercial artificial tear preparations was determined with a modified TRAP procedure. The two preparations with the strongest anti-oxidative effect were then examined for their protective effects against UV or ozone exposure in a hyaluronate model.
RESULTS: Of 19 artificial tear preparations tested, only 6 showed strong to moderate anti-oxidative effects. All others were at best weakly anti-oxidative or had no anti-oxidative effect at all. Some of them even acted as oxidants. Although the two most strongly anti-oxidative preparations performed somewhat differently on UV and ozone exposure, they were both found to be highly protective against these important oxidative stress factors.
CONCLUSIONS: The anti-oxidative capacity of artificial tear preparations varies widely. While some are strong anti-oxidants, others are less active or even act as oxidants. If the carefully elicited history of patients with dry eyes suggests that noxious environmental factors may be causally involved, artificial tears which are not just lubricants or contain wetting agents, but act as anti-oxidants, should be chosen for treatment from the many commercially available preparations. Such an etiology-oriented concept would probably improve the success rate of treatment for dry eyes.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11405072     DOI: 10.1007/s004170000237

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  6 in total

1.  Evaluation of oxidative stress levels in the conjunctival epithelium of patients with or without dry eye, and dry eye patients treated with preservative-free hyaluronic acid 0.15 % and vitamin B12 eye drops.

Authors:  Angelo Macri; Chiara Scanarotti; Anna Maria Bassi; Sebastiano Giuffrida; Giorgio Sangalli; Carlo Enrico Traverso; Michele Iester
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-11-16       Impact factor: 3.117

2.  Iodide iontophoresis as a treatment for dry eye syndrome.

Authors:  J Horwath-Winter; O Schmut; E-M Haller-Schober; A Gruber; G Rieger
Journal:  Br J Ophthalmol       Date:  2005-01       Impact factor: 4.638

3.  The effect of iodide iontophoresis on the antioxidative capacity of the tear fluid.

Authors:  Gebhard Rieger; Manfred Klieber; Wolfgang Schimetta; Werner Pölz; Sirid Griebenow; Rudolf Winkler; Jutta Horwath-Winter; Otto Schmut; Birgit Spitzer-Sonnleitner
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-05-23       Impact factor: 3.117

4.  Nerve Growth Factor (NGF) as Partaker in the Modulation of UV-Response in Cultured Human Conjunctival Fibroblasts.

Authors:  Graziana Esposito; Bijorn Omar Balzamino; Maria Luisa Rocco; Luigi Aloe; Alessandra Micera
Journal:  Int J Mol Sci       Date:  2022-06-06       Impact factor: 6.208

5.  Iodide protection from UVB irradiation-induced degradation of hyaluronate and against UVB-damage of human conjunctival fibroblasts.

Authors:  Otto Schmut; Jutta Horwath-Winter; Gebhard Rieger; Rudolf Winkler; Gabriele Trummer; Helga Spitzenberger; Christa Wachswender
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-12-16       Impact factor: 3.117

6.  Comparative antioxidant activity of various ophthalmic product types for artificial tears under different experimental conditions.

Authors:  Sanda Jurja; Ticuta Negreanu-Pirjol; Monica Vasile; Mihaela Hincu; Radu Ciuluvica; Bogdan-Stefan Negreanu-Pirjol
Journal:  Exp Ther Med       Date:  2022-03-15       Impact factor: 2.447

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.